Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 7
2004 4
2005 1
2006 6
2007 4
2008 8
2009 5
2010 17
2011 15
2012 15
2013 31
2014 8
2015 9
2016 15
2017 24
2018 24
2019 9
2020 18
2021 23
2022 10
2023 16
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. Swen JJ, et al. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. Lancet. 2023. PMID: 36739136 Clinical Trial.
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.
Ottaiano A, Santorsola M, Circelli L, Trotta AM, Izzo F, Perri F, Cascella M, Sabbatino F, Granata V, Correra M, Tarotto L, Stilo S, Fiore F, Martucci N, Rocca A, Picone C, Muto P, Borzillo V, Belli A, Patrone R, Mercadante E, Tatangelo F, Ferrara G, Di Mauro A, Scognamiglio G, Berretta M, Capuozzo M, Lombardi A, Galon J, Gualillo O, Pace U, Delrio P, Savarese G, Scala S, Nasti G, Caraglia M. Ottaiano A, et al. Among authors: berretta m. Cancers (Basel). 2023 Mar 17;15(6):1827. doi: 10.3390/cancers15061827. Cancers (Basel). 2023. PMID: 36980713 Free PMC article. Review.
Idarubicin.
Crivellari D, Toffoli G, Lombardi D, Berretta M, Sorio R, Magri MD, Spazzapan S, Scuderi C, Veronesi A. Crivellari D, et al. Among authors: berretta m. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S73-4. doi: 10.1177/030089160208800122. Tumori. 2002. PMID: 11989932 No abstract available.
Chemotherapy-Induced Hepatotoxicity in HIV Patients.
Bressan S, Pierantoni A, Sharifi S, Facchini S, Quagliarello V, Berretta M, Montopoli M. Bressan S, et al. Among authors: berretta m. Cells. 2021 Oct 25;10(11):2871. doi: 10.3390/cells10112871. Cells. 2021. PMID: 34831094 Free PMC article. Review.
Primary Cutaneous B-Cell Lymphomas with Large Cell Morphology: A Practical Review.
Ronchi A, Vitiello P, D'Abbronzo G, Caccavale S, Argenziano G, Sica A, Alfano R, Savarese G, Berretta M, Cozzolino I, Franco R. Ronchi A, et al. Among authors: berretta m. Int J Mol Sci. 2023 Mar 25;24(7):6204. doi: 10.3390/ijms24076204. Int J Mol Sci. 2023. PMID: 37047176 Free PMC article. Review.
Physical Needs of Long-term Cancer Patients.
Tralongo P, Pescarenico MG, Surbone A, Bordonaro S, Berretta M, DI Mari A. Tralongo P, et al. Among authors: berretta m. Anticancer Res. 2017 Sep;37(9):4733-4746. doi: 10.21873/anticanres.11880. Anticancer Res. 2017. PMID: 28870892 Review.
Cancer Targeted Therapy Strategy: The Pathologist's Perspectives.
Alessandrini L, Perin T, Kadare S, Del Pup L, Memeo L, Steffan A, Colarossi L, Berretta M, De Paoli P, Canzonieri V. Alessandrini L, et al. Among authors: berretta m. Curr Cancer Drug Targets. 2018;18(5):410-420. doi: 10.2174/1568009618666171129145703. Curr Cancer Drug Targets. 2018. PMID: 29189158 Review.
Glutathione: Lights and Shadows in Cancer Patients.
Marini HR, Facchini BA, di Francia R, Freni J, Puzzolo D, Montella L, Facchini G, Ottaiano A, Berretta M, Minutoli L. Marini HR, et al. Among authors: berretta m. Biomedicines. 2023 Aug 8;11(8):2226. doi: 10.3390/biomedicines11082226. Biomedicines. 2023. PMID: 37626722 Free PMC article. Review.
Epithelial-mesenchymal transition in prostate cancer: an overview.
Montanari M, Rossetti S, Cavaliere C, D'Aniello C, Malzone MG, Vanacore D, Di Franco R, La Mantia E, Iovane G, Piscitelli R, Muscariello R, Berretta M, Perdonà S, Muto P, Botti G, Bianchi AAM, Veneziani BM, Facchini G. Montanari M, et al. Among authors: berretta m. Oncotarget. 2017 May 23;8(21):35376-35389. doi: 10.18632/oncotarget.15686. Oncotarget. 2017. PMID: 28430640 Free PMC article. Review.
247 results